2906
H. Liu et al. / Tetrahedron: Asymmetry 16 (2005) 2901–2907
(rotation of the N-formyl group in solution), major
rotamer: HNMR (300 MHz CDCl3): d (ppm) 0.92 (t,
3.3.6. N-[1-(4-Methoxyphenyl)propyl]formamide 10g.7a
20
1
Yield: 91%;colorless oil; ½a ¼ þ132.6 (c 0.39, CHCl3);
D
J = 7.4 Hz, 3H, CH3), 1.74–1.91 (m, 2H, CH2), 4.93
(q, J = 7.7 Hz, 1H, CH), 5.88 (br s, 1H, NH), 7.11–
7.32 (m, 4H, HAr), 8.27 (s, 1H, CHO); 13C NMR
(75 MHz, CDCl3): d (ppm) 10.72, 29.12, 53.42, 125.07,
126.74, 127.80, 130.11, 134.70, 143.83, 160.60;IR
(KBr): m = 3276 (s), 1660 (s), 1534 (s) cmÀ1. Enantio-
meric excess: 95%, determined by GC (CP-Chirasil
Dex column, Tc = 180 °C, H2 = 12 Psi, S-isomer, tR =
4.61 min and R-isomer, tR = 4.73 min).
1H NMR shows a 3.1: 1 mixture of two rotamers (rota-
tion of the N-formyl group in solution), major rotamer:
1H NMR (300 MHz, CDCl3):
d (ppm) 0.91 (t,
J = 7.4 Hz, 3H, CH3), 1.74–1.90 (m, 2H, CH2), 3.79 (s,
3H, OCH3), 4.92 (q, J = 7.8 Hz, 1H, CH), 5.85 (br s,
1H, NH), 6.88 (d, J = 8.7 Hz, 2H, HAr), 7.22 (d,
J = 8.7 Hz, 2H, HAr), 8.17 (s, 1H, CHO); 13C NMR
(75 MHz, CDCl3): d (ppm) 10.78, 29.07, 53.12, 55.41,
114.20, 127.89, 133.89, 159.04, 160.49. Enantiomeric ex-
cess: 90%, determined by GC (CP-Chirasil Dex column,
Tc = 175 °C, H2 = 12 Psi, S-isomer, tR = 8.67, R-iso-
mer, tR = 8.88 min).
3.3.3. N-(1-Phenylpropyl)formamide 10d.7a Yield:
20
D
1
90%;colorless oil; ½a ¼ þ126.2 (c 0.48, CHCl3); H
NMR shows a 3.2:1 mixture of two rotamers (rotation
of the N-formyl group in solution), major rotamer: H
1
3.3.7.
N-[1-(4-Cyanophenyl)propyl]formamide
10h.
22
NMR (300 MHz, CDCl3): d (ppm) 1.04 (t, J = 7.4 Hz,
3H, CH3), 1.91–2.04 (m, 2H, CH2), 5.08 (q,
J = 7.4 Hz, 1H, CH), 6.13 (br s, 1H, NH), 7.35–7.49
(m, 5H, HAr), 8.31 (s, 1H, CHO); 13C NMR (75 MHz,
CDCl3): d (ppm) 10.79, 29.18, 53.85, 126.70, 127.62,
Yield: 84%;colorless oil; ½a ¼ þ49.3 (c 1.75, CHCl3);
D
1H NMR shows a 6.5:1 mixture of two rotamers (rota-
tion of the N-formyl group in solution), major rotamer:
1H NMR (300 MHz, CDCl3):
d (ppm) 0.90 (t,
J = 7.4 Hz, 3H, CH3), 1.77–1.87 (m, 2H, CH2), 4.97
(q, J = 7.4 Hz, 1H, CH), 5.97 (br s, 1H, NH), 7.37–
7.40 (d, J = 8.3 Hz, 2H, HAr), 7.60–7.64 (d,
J = 8.3 Hz, 2H, HAr), 8.22 (s, 1H, CHO); 13C NMR
(75 MHz, CDCl3): d (ppm) 10.66, 29.01, 53.70, 118.77,
127.44, 132.66, 147.28, 160.71;HRESI-MS (positive
ion) C11H12N2O ([M+H]+) requires 211.0842. Found
211.0849;IR (KBr): m = 3250 (s), 2227 (s), 1665 (s),
1550 (s) cmÀ1. Enantiomeric excess: 92%, determined
by GC (CP-Chirasil Dex column, Tc = 180 °C, H2 =
12 Psi, S-isomer, tR = 23.31, R-isomer, tR = 23.74 min).
128.82, 141.67, 160.59;Minor rotamer:
1HNMR
(300 MHz, CDCl3): d (ppm) 1.07 (t, J = 7.4 Hz, 3H,
CH3), 1.91–2.04 (m, 2H, CH2), 4.48 (q, J = 7.4 Hz,
1H, CH), 6.55 (br s, 1H, NH), 7.35–7.49 (m, 5H,
HAr), 8.24 (d, J = 11.9 Hz, 1H, CHO); 13C NMR
(75 MHz, CDCl3): d (ppm) 10.79, 30.42, 58.21, 126.30,
127.86, 129.00, 141.67, 164.60. Enantiomeric excess:
88%, determined by GC (CP-Chirasil Dex column,
Tc = 160 °C, H2 = 12 Psi, S-isomer, tR = 4.77 min and
R-isomer, tR = 4.89 min).
3.3.4.
N-[1-(4-Chlorophenyl)propyl]formamide
10e.
3.3.8. N-[1-(4-(Trifluoromethyl)phenyl)propyl]formamide
10i. Yield: 93%;white solid, mp 85–88
20
Yield: 96%;white solid, mp 97–100 °C; ½a ¼ þ130.6
°C;
D
(c 0.68, CHCl3); 1H NMR shows a 3.9:1 mixture of
two rotamers (rotation of the N-formyl group in solu-
20
1
½a ¼ þ91.5 (c 0.82, CHCl3); H NMR shows a 4.8:1
miDxture of two rotamers (rotation of the N-formyl
group in solution), major rotamer: 1H NMR
(300 MHz, CDCl3): d (ppm) 0.90 (t, J = 7.4 Hz, 3H,
CH3), 1.80–1.89 (m, 2H, CH2), 5.00 (q, J = 7.4 Hz,
1H, CH), 5.92 (br s, 1H, NH), 7.38–7.40 (d,
J = 8.3 Hz, 2H, HAr), 7.58–7.60 (d, J = 8.3 Hz, 2H,
HAr), 8.21 (s, 1H, CHO); 13C NMR (75 MHz, CDCl3):
d (ppm) 10.37, 28.81, 53.26, 125.57, 126.40, 126.71,
145.47, 160.35;HRESI-MS (positive ion) C 11H12F3NO
([M+H]+) requires 254.0763. Found 254.0787;IR
(KBr): m = 3323 (s), 1662 (s), 1523 (s) cmÀ1. Enantio-
meric excess: 94%, determined by GC (CP-Chirasil
Dex column, Tc = 175 °C, H2 = 12 Psi, S-isomer,
tR = 3.24, R-isomer, tR = 3.39 min).
1
tion), major rotamer: H NMR (300 MHz, CDCl3): d
(ppm) 0.93 (t, J = 7.4 Hz, 3H, CH3), 1.78–1.90 (m,
2H, CH2), 4.93 (q, J = 7.4 Hz, 1H, CH), 5.76 (br s,
1H, NH), 7.21–7.24 (d, J = 6.7 Hz, 2H, HAr), 7.30–
7.32 (d, J = 6.7 Hz, 2H, HAr), 8.21 (s, 1H, CHO); 13C
NMR (75 MHz, CDCl3): d (ppm) 10.70, 29.09, 53.37
(t, CH), 128.13, 129.03, 133.43, 140.17, 160.71. Anal.
Calcd for C10H12ClNO: C, 60.76;H, 6.12;N, 7.09.
Found C, 60.58;H, 6.08;N, 7.06. Enantiomeric excess:
94%, determined by GC (CP-Chirasil Dex column,
Tc = 180 °C, H2 = 12 Psi, S-isomer, tR = 5.82 min and
R-isomer, tR = 5.95 min).
3.3.5. N-[1-p-Tolypropyl]formamide 10f.7a Yield: 90%;
20
1
colorless oil; ½a ¼ þ122.3 (c 0.54, CHCl3); HNMR
3.3.9. 4-(1-Formylaminopropyl)benzoic acid methyl ester
shows a 3.3:1 mDixture of two rotamers (rotation of the
N-formyl group in solution), major rotamer: H NMR
20
10j.7a 71%;white solid, mp 139–141 °C; ½a ¼ þ41 (c
D
1
1
0.57, CHCl3); H NMR shows a 5.1:1 mixture of two
(300 MHz, CDCl3): d (ppm) 0.91 (t, J = 7.4 Hz, 3H,
CH3), 1.73–1.87 (m, 2H, CH2), 2.33 (s, 3H, ArCH3),
4.93 (q, J = 7.7 Hz, 1H, CH), 5.84 (br s, 1H, NH),
7.10–7.19 (m, 4H, HAr), 8.18 (s, 1H, CHO); 13C NMR
(75 MHz, CDCl3): d (ppm) 10.78, 21.19, 29.12, 53.60,
126.64, 129.52, 137.34, 138.64, 160.50. Enantiomeric
excess: 91%, determined by GC (CP-Chirasil Dex
column, Tc = 160 °C, H2 = 12 Psi, S-isomer, tR = 6.45
min and R-isomer, tR = 6.60 min).
rotamers (rotation of the N-formyl group in solution),
major rotamer: H NMR (300 MHz, CDCl3): d (ppm)
1
0.92 (t, J = 7.1 Hz, 3H, CH3), 1.80–1.90 (p,
J = 7.3 Hz, 2H, CH2), 3.91 (s, 3H, CO2CH3), 5.00 (q,
J = 7.6 Hz, 1H, CH), 5.91 (br s, 1H, NH), 7.34 (d,
J = 8.5 Hz, 2H, HAr), 7.99 (d, J = 8.3 Hz, 2H, HAr),
8.23 (s, 1H, CHO); 13C NMR (75 MHz, CDCl3): d
(ppm) 10.68, 29.15, 52.34, 53.65, 126.70, 130.10,
130.18, 146.87, 160.63, 166.92. Enantiomeric excess: